Results 141 to 150 of about 22,313 (262)

LDL-cholesterol lowering: timing is everything. [PDF]

Am J Prev Cardiol
Razavi AC, Blumenthal RS.
europepmc   +1 more source

Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives

Human Psychopharmacology: Clinical and Experimental, Volume 41, Issue 5, September 2026.
ABSTRACT Objective This review critically examines psilocybin, with particular emphasis on its pharmacokinetics and pharmacodynamics, including its serotonergic, neuroplastic, and anti‐inflammatory mechanisms. It integrates historical context, preclinical and clinical evidence, and evaluates emerging therapeutic potential, safety, microdosing practices,
José Norberto Vásquez‐Bonilla
wiley   +1 more source

Replacing daily cART with AAV-expressed eCD4-Ig

Journal of Virus Eradication, 2019
M. Gardner, M. Davis-Gardner, M. Farzan
doaj   +1 more source

Post-traumatic radioulnar synostosis following forearm fracture osteosynthesis treated by excision and fascia lata interposition: A case report. [PDF]

Trauma Case Rep
Hssain I, Abdenaji S, El Kassimi C, Rahmi M, Rafai M.   +4 more
europepmc   +1 more source

Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review

Journal of Clinical Psychology, Volume 82, Issue 9, Page 1263-1270, September 2026.
ABSTRACT Recent studies have shown promising results for psychedelics in the treatment of psychiatric disorders. Both in clinical and recreational settings, contextual elements, such as music, can influence the experience of users and may be linked to positive outcomes.
Lucas Cruz, Fernando R. Beserra, Julia M. K. Freind, Sandro E. Rodrigues, Daniel C. Mograbi   +4 more
wiley   +1 more source

WCN25-1779 SUCCESSFUL KIDNEY REPLACEMENT THERAPY IN BERNARD SOULIER SYNDROME ; CHALLENGES FOR NEPHROLOGIST

Kidney International Reports
Aniket Hase, Niwrutti Hase, Dipanjan Haldar, Ankita Hingolikar, Asif Shaikh, Radhika Agarwal, Pratik Hatkar   +6 more
doaj   +1 more source

A bispecific antibody that simultaneously recognises the V2- and V3-glycan epitopes of the HIV-1 envelope glycoprotein

Journal of Virus Eradication, 2019
M. Davis-Gardner, M. Gardner, M. Farzan
doaj   +1 more source

Discovery of Sphaeriaurantins as Rapid-Acting Antiplasmodials with Dual Activity in Blood and Liver Stages. [PDF]

J Am Chem Soc
Bader CD, Collins JE, Li Y, Kalkreuter E, Bhasin J, De Souza ML, Paes Lopez RA, Jeon JH, Boonyalai N, Gui C, Yang D, Fidock DA, Lee MCS, Winzeler EA, Chakrabarti D, Shen B.   +15 more
europepmc   +1 more source

Immune Checkpoint Inhibitors in Cancer Therapy: Clinical Landscape, Resistance Mechanisms, and Therapeutic Innovations

MedComm – Oncology, Volume 5, Issue 3, September 2026.
The up‐to‐date clinical progress of immune checkpoint inhibitor (ICI) therapy in solid tumors, specifically the combinational regimens between ICIs and other treatment strategies, the mechanisms underlying primary and acquired resistance, and mechanism‐matched strategies to improve clinical outcomes are synthesized in this review.
Qiongyu Zhang, Zhi Qin, Caijuan Guo
wiley   +1 more source

Tat inhibition by didehydro-cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat

Journal of Virus Eradication, 2019
C. Li, S. Valente, G. Mousseau
doaj   +1 more source